News
05-26-2010, 05:25 AM
Researchers from the Royal College of Surgeons in Ireland (RCSI) have identified a biomarker in patient blood which can predict the severity of breast cancer in patients and may enable clinicians to track patients throughout the course of their treatment. Around 75 percent of breast cancers are fuelled by the hormone estrogen which encourages them to grow...
More... (http://mnt.to/f/3D63)
More... (http://mnt.to/f/3D63)